Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 4761-4770 Newer>

The Motley Fool December 7, 2004 Wherrett & Yelovich	Lemons Ripen Faster Than Plums A venture capitalist in the nano sector is finding some nice pickings. However, valuing Harris is not an easy task, as the metrics of sales and profits are not relevant to a publicly traded VC company.
The Motley Fool December 7, 2004 Charly Travers	Spin the Medicine Bottle Is a new MS drug going to be a top seller or a bottom-dweller? Here's how to find out. Before investing in any pharmaceutical company with a product in development, go through this exercise to estimate the new drug's potential.
The Motley Fool December 7, 2004 Phil Wohl	America's Car-Mart's Diversity Despite a more than 3% drop in its share price, America's Car-Mart remains a successful niche player that is able to execute an extremely tight and well-thought-out business plan.
The Motley Fool December 7, 2004 W.D. Crotty	A Sad Day for Colgate The company announces a huge four-year restructuring plan. The stock is up 6% on today's news. But, with the stock trading at 20 times consensus earnings, it is hardly cheap.
The Motley Fool December 7, 2004 Seth Jayson	Stanley Swaps Doors for Locks Stanley Works announced plans to focus its business on security. The incoming businesses, Security Group and Cal-Door Specialties, are expected to add 8% to revenues and $0.03-$0.04 per share in earnings. Stanley ponied up roughly one times sales to make the buys, at $56 million.
The Motley Fool December 7, 2004 Brian Gorman	ID Biomedical's Shot in the Arm The company appears well-positioned for the coming years, but it may be best to stay cautious on the company.
The Motley Fool December 7, 2004 Tim Beyers	Profiting From Questions Wondering how a sudden event will impact a company in which you're invested? Don't just stand there, ask.
The Motley Fool December 7, 2004 Tim Beyers	Amazon Blacks Out Outages on Monday mar a successful start to the holiday shopping season. Fourth-quarter guidance calls for revenue of $2.29 billion to $2.54 billion, or growth of as much as 31% over last year.
The Motley Fool December 7, 2004 Rich Smith	InVision Sees End of Tunnel A Department of Justice settlement for violations of the U.S. Foreign Corrupt Practices Act (FCPA) clears the way for acquisition of the tiny bomb detector by GE.
The Motley Fool December 7, 2004 Lawrence Meyers	Investing in Your Kid's Doctor The health-care industry can be the source of big payoffs for investors. People looking to profit from the industry other than by buying stocks like Amgen, Pfizer, or Wellpoint may want to consider Pediatrix at lower prices.
<Older 4761-4770 Newer> Return to current articles.